The Enterprise Value as of June 2026 (TTM) for ORIC Pharmaceuticals, Inc. (ORIC) is 799.69M

According to ORIC Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 799.69M. This represents a change of -16.38% compared to the average of 956.36M of the last 4 quarters.

ORIC Pharmaceuticals, Inc. (ORIC) Historical Enterprise Value (quarterly & annually)

How has ORIC Enterprise Value performed in the past?

The mean historical Enterprise Value of ORIC Pharmaceuticals, Inc. over the last ten years is 311.11M. The current 799.69M Enterprise Value has changed 25.60% with respect to the historical average. Over the past ten years (40 quarters), ORIC's Enterprise Value was at its highest in in the March 2026 quarter at 1.28B. The Enterprise Value was at its lowest in in the December 2019 quarter at -38469410.00.

ORIC Pharmaceuticals, Inc. (ORIC) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of ORIC Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

ORIC Pharmaceuticals, Inc. (ORIC) Average Enterprise Value

How has ORIC Enterprise Value performed in the past?

The current Enterprise Value of ORIC Pharmaceuticals, Inc. (ORIC) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

ORIC Pharmaceuticals, Inc. (ORIC) Enterprise Value vs. Peers

How is ORIC’s Enterprise Value compared to its peers?

ORIC Pharmaceuticals, Inc.’s Enterprise Value is less than Amylyx Pharmaceuticals, Inc. (989.29M), less than Relay Therapeutics, Inc. (2.42B), less than Precigen, Inc. (1.43B), less than Nektar Therapeutics (1.17B), less than Inhibrx Biosciences, Inc. (1.20B), less than Syndax Pharmaceuticals, Inc. (1.83B), less than Terns Pharmaceuticals, Inc. (4.25B), less than Enliven Therapeutics, Inc. (2.68B), less than Tourmaline Bio, Inc. (1.20B), less than Atai Beckley Inc. (1.40B),

Build a custom stock screener for ORIC Pharmaceuticals, Inc. (ORIC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ORIC Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ORIC Pharmaceuticals, Inc. (ORIC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ORIC Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.